Systemic antifibrinolytic agents are widely used in major surgery to prevent fibrinolysis and thus reduce surgical blood loss. A recent systematic review [6] of randomized, controlled trials of ...

Lp(a) possesses thrombotic, antifibrinolytic and atherogenic properties ... This particularly applies to PCSK9 inhibitors as elevation of PCSK9 by statins is an important reason for the limited ...

For endoscopic interventions, recommendations exist on how to administer oral anticoagulants and thrombocyte aggregation inhibitors ... Schutgens RE: Antifibrinolytic therapy for preventing ...